Similarly to colorectal carcinoma, a subset of PDACs with low HNF4α expression are characterized by an amplified WNT/β-catenin signaling program and an increased tolerance to GSK3β inhibitors38. This evidence concerns the gene HNF4A and colorectal carcinoma.